Industry: Medical Devices & Consumables
Published Date: 2025-06-04
Pages: 106 Pages
Report ld: 3422755
Request Sample
Customized Report
Diaphragm Valves for Pharmaceutical Process Market Size(US$)

CAGR 2025-2031
6.5%
Market Size,2031
USD 212
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Diaphragm Valves for Pharmaceutical Process was valued at US$ 139 million in the year 2024 and is projected to reach a revised size of US$ 212 million by 2031, growing at a CAGR of 6.5% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Diaphragm Valves for Pharmaceutical Process competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A Diaphragm valve is a flexible, pressure responsive element that transmits force to throttle, open or close a valve. Diaphragm valves separate the flow stream from the closure element using an elastomeric diaphragm, which is a flexible, durable material. The diaphragm in a valve serves as a seal to prevent the liquid encountering other operating parts of the valve, avoiding contamination, corrosion and wear.
GEMU is one of the most important global key players of the diaphragm valves for pharmaceutical process, holds about 20% of shares of global diaphragm valves for pharmaceutical process market, other key players include Crane Co. (Saunders), SAMSON (SED Flow Control Gmbh), Burkert Fluid Control Systems, etc. Europe is the largest market, occupied for about 30 percent, followed by the Asia Pacific. In terms of materials, stainless steel is the largest segment, with a share of over 60%, and in terms of application, the pharmaceutical water system segment holds a share of over 30 percent.
Analysis of market drivers of diaphragm valves for pharmaceutical processes:
1. Policy compliance and industry standard upgrades
Global drug regulation is becoming stricter
FDA/EU GMP requirements: Aseptic preparation production must meet zero leakage standards, which promotes the upgrade of diaphragm valve materials (such as PTFE, EPDM) and sealing technology.
Data integrity specifications: For example, the GAMP5 guideline requires valves to have electronic recording functions, which supports pharmaceutical companies to pass FDA 21 CFR Part 11 certification.
China's policy promotion
The "Drug Production Supervision and Management Measures" requires regular verification of sterile drug production equipment, driving the demand for diaphragm valve replacement.
Tightening environmental protection policies have forced companies to adopt corrosion-resistant, low-leakage diaphragm valves to reduce waste liquid treatment costs.
2. Technological innovation and product iteration
Breakthrough in material science
The temperature tolerance of high-purity PTFE diaphragms has been increased to 180°C, which is compatible with SIP/CIP processes and reduces equipment downtime.
Metal diaphragm valves (such as Hastelloy) are used in highly corrosive media to extend their service life to more than 10 years.
Intelligent integration
Integrated sensors enable real-time monitoring of flow and pressure. For example, the GEMU 69X series supports the IO-Link protocol to improve process control accuracy.
Automated cleaning module (CIP) and diaphragm valve integrated design reduce cross-contamination risk.
Miniaturization and modularization
Micro diaphragm valves (diameter ≤ 6mm) are suitable for emerging scenarios such as bioreactors and microfluidic chips to promote the production of cell therapy drugs.
Modular design supports rapid replacement of valve cores and shortens equipment maintenance time.
III. Global pharmaceutical industry expansion
Breaking up of biopharmaceutical production capacity
The global biopharmaceutical market size is expected to reach US$560 billion in 2028. The production of monoclonal antibodies and ADC drugs requires high-purity diaphragm valves to control culture media/buffers.
Chinese biopharmaceutical companies (such as BeiGene and Hengrui Medicine) are accelerating factory construction, driving the growth of local diaphragm valve demand.
The rise of the CDMO industry
The global TOP10 CDMO companies (such as Lonza and Catalent) have expanded their production capacity, driving the scale of standardized diaphragm valve procurement.
Modular factories (such as GE Healthcare's KUBio) use pre-installed diaphragm valve systems to shorten project delivery cycles.
Penetration in emerging markets
The growth of generic drug production in India and Southeast Asia has driven the demand for cost-effective diaphragm valves.
The growth of the diaphragm valve market for pharmaceutical processes is driven by policy compliance, technological innovation, industrial expansion and supply chain reconstruction. In the future, companies need to focus on high-end material research and development, intelligent integration and global layout, while grasping high-growth tracks such as biopharmaceuticals and CDMO to cope with cost pressures and technical barriers and consolidate their market position.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Diaphragm Valves for Pharmaceutical Process, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diaphragm Valves for Pharmaceutical Process.
The Diaphragm Valves for Pharmaceutical Process market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diaphragm Valves for Pharmaceutical Process market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diaphragm Valves for Pharmaceutical Process manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GEMU
Crane Co.(Saunders)
SAMSON (SED Flow Control Gmbh)
Burkert Fluid Control Systems
INOXPA SAU
Aquasyn
Alfa Laval
ITT
NDV
Hylok
Swagelok
Parker Hannifin
Watson-Marlow Fluid Technology Group (ASEPCO)
Steel & O'Brien
Shanghai REMY
Rodaff Fluid Tech
Segment by Type
Stainless Steel
Plastic
Others
Segment by Application
Pharmaceutical Water System
CIP and SIP System
Filtration and Filling
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diaphragm Valves for Pharmaceutical Process manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diaphragm Valves for Pharmaceutical Process in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Diaphragm Valves for Pharmaceutical Process Market Overview
1.1 Product Definition
1.2 Diaphragm Valves for Pharmaceutical Process by Type
1.2.1 Global Diaphragm Valves for Pharmaceutical Process Market Value Comparison by Type (2024 VS 2031)
1.2.2 Stainless Steel
1.2.3 Plastic
1.2.4 Others
1.3 Diaphragm Valves for Pharmaceutical Process by Application
1.3.1 Global Diaphragm Valves for Pharmaceutical Process Market Value by Application (2024 VS 2031)
1.3.2 Pharmaceutical Water System
1.3.3 CIP and SIP System
1.3.4 Filtration and Filling
1.3.5 Others
1.4 Global Diaphragm Valves for Pharmaceutical Process Market Size Estimates and Forecasts
1.4.1 Global Diaphragm Valves for Pharmaceutical Process Revenue 2020-2031
1.4.2 Global Diaphragm Valves for Pharmaceutical Process Sales 2020-2031
1.4.3 Global Diaphragm Valves for Pharmaceutical Process Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Diaphragm Valves for Pharmaceutical Process Market Competition by Manufacturers
2.1 Global Diaphragm Valves for Pharmaceutical Process Sales Market Share by Manufacturers (2020-2025)
2.2 Global Diaphragm Valves for Pharmaceutical Process Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Diaphragm Valves for Pharmaceutical Process Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Diaphragm Valves for Pharmaceutical Process, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diaphragm Valves for Pharmaceutical Process, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diaphragm Valves for Pharmaceutical Process, Product Type & Application
2.7 Global Key Manufacturers of Diaphragm Valves for Pharmaceutical Process, Date of Enter into This Industry
2.8 Global Diaphragm Valves for Pharmaceutical Process Market Competitive Situation and Trends
2.8.1 Global Diaphragm Valves for Pharmaceutical Process Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Diaphragm Valves for Pharmaceutical Process Players Market Share by Revenue
2.8.3 Global Diaphragm Valves for Pharmaceutical Process Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Diaphragm Valves for Pharmaceutical Process Market Scenario by Region
3.1 Global Diaphragm Valves for Pharmaceutical Process Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Diaphragm Valves for Pharmaceutical Process Sales by Region: 2020-2031
3.2.1 Global Diaphragm Valves for Pharmaceutical Process Sales by Region: 2020-2025
3.2.2 Global Diaphragm Valves for Pharmaceutical Process Sales by Region: 2026-2031
3.3 Global Diaphragm Valves for Pharmaceutical Process Revenue by Region: 2020-2031
3.3.1 Global Diaphragm Valves for Pharmaceutical Process Revenue by Region: 2020-2025
3.3.2 Global Diaphragm Valves for Pharmaceutical Process Revenue by Region: 2026-2031
3.4 North America Diaphragm Valves for Pharmaceutical Process Market Facts & Figures by Country
3.4.1 North America Diaphragm Valves for Pharmaceutical Process Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Diaphragm Valves for Pharmaceutical Process Sales by Country (2020-2031)
3.4.3 North America Diaphragm Valves for Pharmaceutical Process Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diaphragm Valves for Pharmaceutical Process Market Facts & Figures by Country
3.5.1 Europe Diaphragm Valves for Pharmaceutical Process Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Diaphragm Valves for Pharmaceutical Process Sales by Country (2020-2031)
3.5.3 Europe Diaphragm Valves for Pharmaceutical Process Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diaphragm Valves for Pharmaceutical Process Market Facts & Figures by Region
3.6.1 Asia Pacific Diaphragm Valves for Pharmaceutical Process Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Diaphragm Valves for Pharmaceutical Process Sales by Region (2020-2031)
3.6.3 Asia Pacific Diaphragm Valves for Pharmaceutical Process Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Diaphragm Valves for Pharmaceutical Process Market Facts & Figures by Country
3.7.1 Latin America Diaphragm Valves for Pharmaceutical Process Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Diaphragm Valves for Pharmaceutical Process Sales by Country (2020-2031)
3.7.3 Latin America Diaphragm Valves for Pharmaceutical Process Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diaphragm Valves for Pharmaceutical Process Market Facts & Figures by Country
3.8.1 Middle East and Africa Diaphragm Valves for Pharmaceutical Process Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Diaphragm Valves for Pharmaceutical Process Sales by Country (2020-2031)
3.8.3 Middle East and Africa Diaphragm Valves for Pharmaceutical Process Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diaphragm Valves for Pharmaceutical Process Sales by Type (2020-2031)
4.1.1 Global Diaphragm Valves for Pharmaceutical Process Sales by Type (2020-2025)
4.1.2 Global Diaphragm Valves for Pharmaceutical Process Sales by Type (2026-2031)
4.1.3 Global Diaphragm Valves for Pharmaceutical Process Sales Market Share by Type (2020-2031)
4.2 Global Diaphragm Valves for Pharmaceutical Process Revenue by Type (2020-2031)
4.2.1 Global Diaphragm Valves for Pharmaceutical Process Revenue by Type (2020-2025)
4.2.2 Global Diaphragm Valves for Pharmaceutical Process Revenue by Type (2026-2031)
4.2.3 Global Diaphragm Valves for Pharmaceutical Process Revenue Market Share by Type (2020-2031)
4.3 Global Diaphragm Valves for Pharmaceutical Process Price by Type (2020-2031)
5 Segment by Application
5.1 Global Diaphragm Valves for Pharmaceutical Process Sales by Application (2020-2031)
5.1.1 Global Diaphragm Valves for Pharmaceutical Process Sales by Application (2020-2025)
5.1.2 Global Diaphragm Valves for Pharmaceutical Process Sales by Application (2026-2031)
5.1.3 Global Diaphragm Valves for Pharmaceutical Process Sales Market Share by Application (2020-2031)
5.2 Global Diaphragm Valves for Pharmaceutical Process Revenue by Application (2020-2031)
5.2.1 Global Diaphragm Valves for Pharmaceutical Process Revenue by Application (2020-2025)
5.2.2 Global Diaphragm Valves for Pharmaceutical Process Revenue by Application (2026-2031)
5.2.3 Global Diaphragm Valves for Pharmaceutical Process Revenue Market Share by Application (2020-2031)
5.3 Global Diaphragm Valves for Pharmaceutical Process Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GEMU
6.1.1 GEMU Company Information
6.1.2 GEMU Description and Business Overview
6.1.3 GEMU Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GEMU Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.1.5 GEMU Recent Developments/Updates
6.2 Crane Co.(Saunders)
6.2.1 Crane Co.(Saunders) Company Information
6.2.2 Crane Co.(Saunders) Description and Business Overview
6.2.3 Crane Co.(Saunders) Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Crane Co.(Saunders) Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.2.5 Crane Co.(Saunders) Recent Developments/Updates
6.3 SAMSON (SED Flow Control Gmbh)
6.3.1 SAMSON (SED Flow Control Gmbh) Company Information
6.3.2 SAMSON (SED Flow Control Gmbh) Description and Business Overview
6.3.3 SAMSON (SED Flow Control Gmbh) Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.3.4 SAMSON (SED Flow Control Gmbh) Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.3.5 SAMSON (SED Flow Control Gmbh) Recent Developments/Updates
6.4 Burkert Fluid Control Systems
6.4.1 Burkert Fluid Control Systems Company Information
6.4.2 Burkert Fluid Control Systems Description and Business Overview
6.4.3 Burkert Fluid Control Systems Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Burkert Fluid Control Systems Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.4.5 Burkert Fluid Control Systems Recent Developments/Updates
6.5 INOXPA SAU
6.5.1 INOXPA SAU Company Information
6.5.2 INOXPA SAU Description and Business Overview
6.5.3 INOXPA SAU Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.5.4 INOXPA SAU Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.5.5 INOXPA SAU Recent Developments/Updates
6.6 Aquasyn
6.6.1 Aquasyn Company Information
6.6.2 Aquasyn Description and Business Overview
6.6.3 Aquasyn Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Aquasyn Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.6.5 Aquasyn Recent Developments/Updates
6.7 Alfa Laval
6.7.1 Alfa Laval Company Information
6.7.2 Alfa Laval Description and Business Overview
6.7.3 Alfa Laval Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Alfa Laval Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.7.5 Alfa Laval Recent Developments/Updates
6.8 ITT
6.8.1 ITT Company Information
6.8.2 ITT Description and Business Overview
6.8.3 ITT Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.8.4 ITT Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.8.5 ITT Recent Developments/Updates
6.9 NDV
6.9.1 NDV Company Information
6.9.2 NDV Description and Business Overview
6.9.3 NDV Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.9.4 NDV Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.9.5 NDV Recent Developments/Updates
6.10 Hylok
6.10.1 Hylok Company Information
6.10.2 Hylok Description and Business Overview
6.10.3 Hylok Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hylok Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.10.5 Hylok Recent Developments/Updates
6.11 Swagelok
6.11.1 Swagelok Company Information
6.11.2 Swagelok Description and Business Overview
6.11.3 Swagelok Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Swagelok Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.11.5 Swagelok Recent Developments/Updates
6.12 Parker Hannifin
6.12.1 Parker Hannifin Company Information
6.12.2 Parker Hannifin Description and Business Overview
6.12.3 Parker Hannifin Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Parker Hannifin Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.12.5 Parker Hannifin Recent Developments/Updates
6.13 Watson-Marlow Fluid Technology Group (ASEPCO)
6.13.1 Watson-Marlow Fluid Technology Group (ASEPCO) Company Information
6.13.2 Watson-Marlow Fluid Technology Group (ASEPCO) Description and Business Overview
6.13.3 Watson-Marlow Fluid Technology Group (ASEPCO) Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Watson-Marlow Fluid Technology Group (ASEPCO) Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.13.5 Watson-Marlow Fluid Technology Group (ASEPCO) Recent Developments/Updates
6.14 Steel & O'Brien
6.14.1 Steel & O'Brien Company Information
6.14.2 Steel & O'Brien Description and Business Overview
6.14.3 Steel & O'Brien Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Steel & O'Brien Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.14.5 Steel & O'Brien Recent Developments/Updates
6.15 Shanghai REMY
6.15.1 Shanghai REMY Company Information
6.15.2 Shanghai REMY Description and Business Overview
6.15.3 Shanghai REMY Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shanghai REMY Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.15.5 Shanghai REMY Recent Developments/Updates
6.16 Rodaff Fluid Tech
6.16.1 Rodaff Fluid Tech Company Information
6.16.2 Rodaff Fluid Tech Description and Business Overview
6.16.3 Rodaff Fluid Tech Diaphragm Valves for Pharmaceutical Process Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Rodaff Fluid Tech Diaphragm Valves for Pharmaceutical Process Product Portfolio
6.16.5 Rodaff Fluid Tech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diaphragm Valves for Pharmaceutical Process Industry Chain Analysis
7.2 Diaphragm Valves for Pharmaceutical Process Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diaphragm Valves for Pharmaceutical Process Production Mode & Process Analysis
7.4 Diaphragm Valves for Pharmaceutical Process Sales and Marketing
7.4.1 Diaphragm Valves for Pharmaceutical Process Sales Channels
7.4.2 Diaphragm Valves for Pharmaceutical Process Distributors
7.5 Diaphragm Valves for Pharmaceutical Process Customer Analysis
8 Diaphragm Valves for Pharmaceutical Process Market Dynamics
8.1 Diaphragm Valves for Pharmaceutical Process Industry Trends
8.2 Diaphragm Valves for Pharmaceutical Process Market Drivers
8.3 Diaphragm Valves for Pharmaceutical Process Market Challenges
8.4 Diaphragm Valves for Pharmaceutical Process Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Diaphragm Valves for Pharmaceutical Process market size was US$ 145 million in 2025 and is forecast to reach a readjusted size of US$ 225 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 101
USD 4250.00
(Single User License)
The global Diaphragm Valves for Pharmaceutical Process market was valued at US$ 145 million in 2025 and is anticipated to reach US$ 225 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 137
USD 2900.00
(Single User License)
The global market for Diaphragm Valves for Pharmaceutical Process was estimated to be worth US$ 145 million in 2025 and is projected to reach US$ 225 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 150
USD 3950.00
(Single User License)
The global Diaphragm Valves for Pharmaceutical Process market size was US$ 139 million in 2024 and is forecast to a readjusted size of US$ 212 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 107
USD 4250.00
(Single User License)
The global Diaphragm Valves for Pharmaceutical Process market is projected to grow from US$ 139 million in 2024 to US$ 212 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 172
USD 4900.00
(Single User License)
The global market for Diaphragm Valves for Pharmaceutical Process was estimated to be worth US$ 139 million in 2024 and is forecast to a readjusted size of US$ 212 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-06-04
Pages: 140
USD 3950.00
(Single User License)
The global Diaphragm Valves for Pharmaceutical Process market is projected to grow from US$ 145 million in 2025 to US$ 212 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
Published Date: 2025-06-04
Pages: 169
USD 4900.00
(Single User License)
The global market for Diaphragm Valves for Pharmaceutical Process was estimated to be worth US$ 109 million in 2024 and is forecast to a readjusted size of US$ 172 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 132
USD 3950.00
(Single User License)
A Diaphragm valve is a flexible, pressure responsive element that transmits force to throttle, open or close a valve. Diaphragm valves separate the flow stream from the closure element using an elastomeric diaphragm, which is a flexible, durable material. The diaphragm in a valve serves as a seal to prevent the liquid encountering other operating parts of the valve, avoiding contamination, corrosion and wear.
Published Date: 2024-01-18
Pages: 134
USD 3950.00
(Single User License)
A Diaphragm valve is a flexible, pressure responsive element that transmits force to throttle, open or close a valve. Diaphragm valves separate the flow stream from the closure element using an elastomeric diaphragm, which is a flexible, durable material. The diaphragm in a valve serves as a seal to prevent the liquid encountering other operating parts of the valve, avoiding contamination, corrosion and wear.
Published Date: 2024-01-03
Pages: 106
USD 2900.00
(Single User License)
The global Diaphragm Valves for Pharmaceutical Process market size was US$ 145 million in 2025 and is forecast to reach a readjusted size of US$ 225 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 101
The global Diaphragm Valves for Pharmaceutical Process market was valued at US$ 145 million in 2025 and is anticipated to reach US$ 225 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 137
The global market for Diaphragm Valves for Pharmaceutical Process was estimated to be worth US$ 145 million in 2025 and is projected to reach US$ 225 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 150
The global Diaphragm Valves for Pharmaceutical Process market size was US$ 139 million in 2024 and is forecast to a readjusted size of US$ 212 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 107
The global Diaphragm Valves for Pharmaceutical Process market is projected to grow from US$ 139 million in 2024 to US$ 212 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 172
The global market for Diaphragm Valves for Pharmaceutical Process was estimated to be worth US$ 139 million in 2024 and is forecast to a readjusted size of US$ 212 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-06-04
Pages: 140
The global Diaphragm Valves for Pharmaceutical Process market is projected to grow from US$ 145 million in 2025 to US$ 212 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
Published: 2025-06-04
Pages: 169
The global market for Diaphragm Valves for Pharmaceutical Process was estimated to be worth US$ 109 million in 2024 and is forecast to a readjusted size of US$ 172 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 132
A Diaphragm valve is a flexible, pressure responsive element that transmits force to throttle, open or close a valve. Diaphragm valves separate the flow stream from the closure element using an elastomeric diaphragm, which is a flexible, durable material. The diaphragm in a valve serves as a seal to prevent the liquid encountering other operating parts of the valve, avoiding contamination, corrosion and wear.
Published: 2024-01-18
Pages: 134
A Diaphragm valve is a flexible, pressure responsive element that transmits force to throttle, open or close a valve. Diaphragm valves separate the flow stream from the closure element using an elastomeric diaphragm, which is a flexible, durable material. The diaphragm in a valve serves as a seal to prevent the liquid encountering other operating parts of the valve, avoiding contamination, corrosion and wear.
Published: 2024-01-03
Pages: 106
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now